Biological in situ Dose Painting for Image-Guided Radiation Therapy Using Drug-Loaded Implantable Devices

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 615-623

  Cormack, Robert A ^a   Sridhar, Srinivas ^b   Suh, W Warren ^a   D'Amico, Anthony V ^a   Makrigiorgos, G Mike ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Brachytherapy seeds; Fiducials; Image guided radiation therapy; Lung SBRT treatment

Indexed keywords

ACTIVE DRUGS; ANALYTIC FUNCTIONS; BIOLOGICALLY EFFECTIVE DOSE; BRACHYTHERAPY; BRACHYTHERAPY SEEDS; CONCENTRATION OF; DRUG DISTRIBUTION; DRUG LOADING; EQUIVALENT DOSE; FIDUCIALS; IMAGE-GUIDED; IMAGE-GUIDED RADIATION THERAPY; IMPLANTABLE DEVICES; IN-SITU; LUNG TUMOR; NEW APPROACHES; NEW OPPORTUNITIES; NORMAL TISSUE; PROSTATE BRACHYTHERAPY; RADIATION TREATMENTS; RADIO-SENSITIZATION; RADIOSENSITIZERS; SLOW RELEASE; SPATIAL ACCURACY; STEREOTACTIC BODY RADIATION THERAPY; TUMOR COVERAGE;

BIOLOGICAL ORGANS; ONCOLOGY; RADIATION; RADIOTHERAPY; THREE DIMENSIONAL; TUMORS;

DRUG DOSAGE;

RADIOSENSITIZING AGENT;

ARTICLE; BRACHYTHERAPY SPACER; CANCER RADIOTHERAPY; DOSIMETRY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG ELIMINATION; FIDUCIAL; IMPLANT; LUNG TUMOR; PRIORITY JOURNAL; RADIOSENSITIZATION; RECTUM; SIMULATION; SLOW DRUG RELEASE; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME; URETHRA;

ALGORITHMS; BRACHYTHERAPY; DELAYED-ACTION PREPARATIONS; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIATION-SENSITIZING AGENTS;

EID: 73649109907     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.039     Document Type: Article

References (27)

1. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
2. 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 46 (2000) 207-214
3. Kaplan I.D., Meskell P., Oldenburg N.E., et al. Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy 5 (2006) 147-151
4. Wurm R.E., Gum F., Erbel S., et al. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol 45 (2006) 881-889
5. Gultepe E., Nagesha D., Menon L., et al. High-throughput assembly of nanoelements in nanoporous alumina templates. Appl Phys Lett 90 (2007) 163119
6. Garcia-Garcia H.M., Vaina S., Tsuchida K., et al. Drug-eluting stents. Arch Cardiol Mex 76 (2006) 297-319
7. Yang C., and Burt H.M. Drug-eluting stents: Factors governing local pharmacokinetics. Adv Drug Deliv Rev 58 (2006) 402-411
8. Li Y., Owusu A., and Lehnert S. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 519-527
9. Doiron A., Yapp D.T., Olivares M., et al. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine. Cancer Res 59 (1999) 3677-3681
10. Crank J. The Mathematics of Diffusion. 2nd edition (1979), Oxford University Press, New York
11. Mak M., Fung L., Strasser J.F., et al. Distribution of drugs following controlled delivery to the brain interstitium. J Neurooncol 26 (1995) 91-102
12. Fung L.K., Ewend M.G., Sills A., et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res 58 (1998) 672-684
13. Chen D., Song D., Wientjes M.G., et al. Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel. Clin Cancer Res 9 (2003) 363-369
14. Li K.W., Dang W., Tyler B.M., et al. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Clin Cancer Res 9 (2003) 3441-3447
15. Maeda H., Wu J., Sawa T., et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 65 (2000) 271-284
16. Tada H., Higuchi H., Wanatabe T.M., et al. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res 67 (2007) 1138-1144
17. Kong G., Braun R.D., and Dewhirst M.W. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 60 (2000) 4440-4445
18. Tishler R.B., Geard C.R., Hall E.J., et al. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52 (1992) 3495-3497
19. Raaphorst G.P., Wang G., Stewart D., et al. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. Int J Radiat Biol 69 (1996) 623-631
20. Castro Kreder N., Van Bree C., Franken N.A., et al. Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation. J Radiat Res (Tokyo) 45 (2004) 111-118
21. von Eckardstein K.L., Patt S., Kratzel C., et al. Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases. J Neurooncol 72 (2005) 209-215
22. Vukelja S.J., Anthony S.P., Arseneau J.C., et al. Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions. Anticancer Drugs 18 (2007) 283-289
23. Jabr-Milane L., van Vlerken L., Devalapally H., et al. Multi-functional nanocarriers for targeted delivery of drugs and genes. J Control Release 130 (2008) 121-128
24. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
25. Li J., Wang L., Mamon H., et al. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med 14 (2008) 579-584
26. Cai W., Chen K., Mohamedali K.A., et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med 47 (2006) 2048-2056
27. Farmer H., McCabe N., Lord C.J., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434 (2005) 917-921